Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Change In Other Working Capital : $938.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Bristol-Myers Squibb Co Change In Other Working Capital?

Bristol-Myers Squibb Co's Change In Other Working Capital for the quarter that ended in Mar. 2024 was $-1,273.00 Mil. It means Bristol-Myers Squibb Co's Other Working Capital declined by $1,273.00 Mil from Dec. 2023 to Mar. 2024 .

Bristol-Myers Squibb Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $237.00 Mil. It means Bristol-Myers Squibb Co's Other Working Capital increased by $237.00 Mil from Dec. 2022 to Dec. 2023 .

Bristol-Myers Squibb Co Change In Other Working Capital Historical Data

The historical data trend for Bristol-Myers Squibb Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Change In Other Working Capital Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

819.00

1,074.00

598.00

-183.00

237.00

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															-1,974.00	665.00	1,474.00	72.00	-1,273.00

Bristol-Myers Squibb Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $938.00 Mil.

Bristol-Myers Squibb Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (NYSE:BMY.R) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.